Health Care Equipment & Services

Abbott EVP Morrone’s latest sale is a routine move amid rising social‑media buzz; investors should watch earnings for potential market shifts.

Insider Burdick Kenneth A sells 500k shares of LIFESTANCE Health Group, raising questions on the company’s telehealth strategy and future confidence.

Insider sales at CVRx show tax‑driven moves amid a 58% YTD slide, yet exec buying signals confidence in its next‑gen implant devices.

Soares Karen’s zero‑cost RSU buy shows Clover Health insiders’ growing confidence, balancing cash‑flow trades with long‑term stake building.

Dexcom insiders trim shares as the G7 sensor drives 10‑week gains—yet the board keeps a bullish long‑term stake, signaling confidence in the company’s growth.

Embecta’s CEO buys shares amid volatility: insider confidence hints at future upside while market swings and low PE keep risk high.

Investor insights: Bausch + Lomb’s recent insider sale is routine vesting, not a warning—strong fundamentals and steady buying still signal a solid long‑term investment.

Insider buying by Jack W Schuler at Biodesix signals confidence in its lung‑cancer diagnostics pipeline, suggesting a potential buying opportunity for investors.

Insider sale alert: CTO Paunovich Vukasin sold 44k LifeStance shares, signaling cautious divestment amid rising telehealth prospects.

Insider selling at Butterfly Network sparks investor concern—learn why executives’ sales could signal shifting confidence or strategic shifts.